Federal Appeals Court Makes Life Harder For Patent Challengers: Tougher Standards For Inequitable Conduct Claims
This article was originally published in The Gray Sheet
Executive SummaryPatent challengers will have a tougher time proving that a patent applicant deceived the patent office under new standards set by the U.S. Court of Appeals for the Federal Circuit.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.